In association with:
October 5-6, 2011 Marriott Copley Place, Boston, MA
Positioning and Partnering for the Biopharma Future Developing a Successful Commercial and Strategic Operation
Industry forecasts indicate that by 2014, 50% of the top 100 and seven of the top 10 drugs will be biologics. The Business Strategies for Biologics Conference provides the Pharma industry with an exceptional platform to formulate growth strategies by understanding the rapidly increasing market for manufacturing biologics.
Hear from industry leaders such as: s Stephen J. O'Keefe, Director, Scientific Liaison Biologics, Merck s Dr. Enric Bosch Radó, Global Sourcing Manager, Boehringer Ingelheim s Rolf Douwenga, VP Global R&D, DSM Biologics s Fi Alonso-Caplen, Senior Director, Biotherapeutics & Vaccines Outsourcing BioTherapeutics Pharmaceutical Sciences, Pfizer
s Mark Bamforth, Chief Executive Officer, Gallus Biopharma
To register, visit www.informex.com/biologics-conference and use code CENBP To inquire about sponsorships, contact: Devin Hader, Account Executive Phone: 609.759.4746 Email:
[email protected] Informex_BSforBiologics_Ad_C&EN.indd 1
8/16/11 10:06:55 AM
